down arrow

Jubilant Pharmo

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE700A01033
  • NSEID: JUBLPHARMA
  • BSEID: 530019
INR
898.15
68.15 (8.21%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Jubilant Pharmova Ltd stock-summary
stock-summary
Jubilant Pharmova Ltd
Mid Cap
Pharmaceuticals & Drugs
Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions. The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
Company Coordinates stock-summary
Company Details
Bhartiagram Gajraula , Amroha Uttar Pradesh : 244223
stock-summary
Tel: 91-5924-267200
stock-summary
investors@jubl.com/support@jubl.com
Registrar Details
Alankit Assignments Ltd , 205-208 , Anarkali Complex, Jhandewala Extension, New Delhi
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 15.93 Cr
Number of Shares
15.93 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
18-Nov-2010
15.93
15.93
501364
1
Amalgamation
18-Nov-2010
15.93
15.93
501364
1
Amalgamation
31-Mar-2010
15.88
15.88
11237517
1
QIB Equity Shares
31-Mar-2010
15.88
15.88
11237517
1
QIB Equity Shares
14-Oct-2008
14.75
14.75
12860
1
ESOP
14-Oct-2008
14.75
14.75
12860
1
ESOP
15-Jul-2008
14.75
14.75
30020
1
ESOP
15-Jul-2008
14.75
14.75
30020
1
ESOP
30-Jun-2008
14.75
14.75
79376
1
FCCB
30-Jun-2008
14.75
14.75
79376
1
FCCB
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 17 Schemes (3.64%)

FIIs

Held by 149 FIIs (16.96%)

Promoter with highest holding

Spb Trustee Company Pvt Ltd (20.52%)

Highest Public shareholder

East Bridge Capital Master Fund I Ltd (3.92%)

Individual Investors Holdings

18.09%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Shyam S Bhartia
Chairman (Non-Executive)
0
Hari S Bhartia
Co-Chairman & Non-Exe.Director
11.99 cr
S Sridhar
Non-Exec. & Independent Dir.
18.9 lacs
Sudha Pillai
Non-Exec. & Independent Dir.
20.1 lacs
Ashok Misra
Non-Exec. & Independent Dir.
17.15 lacs
Vivek Mehra
Non-Exec. & Independent Dir.
18.5 lacs
SUSHIL KUMAR ROONGTA
Non-Exec. & Independent Dir.
17.6 lacs
Priyavrat Bhartia
Managing Director
0
Arjun Shanker Bhartia
Joint Managing Director
0
Arun Seth
Non-Exec. & Independent Dir.
13.8 lacs
Arvind Chokhany
Whole Time Director & CFO
5.34 cr
Naresh Kapoor
Company Sec. & Compli. Officer
0
R Kumar
Whole Time Director
1.64 cr
Shirish Gundopant Belapure
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenue
45.23
1.32%
 
1.32
Other Operating Revenue
98.68
Other Operating Revenue
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,822 Cr
(Quarterly Results - Dec 2024)
Net Profit:
101 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 14,306 Cr (Mid Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.60%

stock-summary
Debt Equity

0.34

stock-summary
Return on Equity

6.57%

stock-summary
Price to Book

2.23